Addressing the challenge of gray-zone medicine
Health care is not a binary world in which interventions are either effective or ineffective, appropriate or inappropriate. Since much health care occurs in gray zones, we need payment and incentive systems that are designed to work within those zones..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:372 |
---|---|
Enthalten in: |
The New England journal of medicine - 372(2015), 3, Seite 203-205 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chandra, Amitabh [VerfasserIn] |
---|
Links: |
---|
RVK: |
---|
doi: |
10.1056/NEJMp1409696 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1968369341 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1968369341 | ||
003 | DE-627 | ||
005 | 20220223153643.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1056/NEJMp1409696 |2 doi | |
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC1968369341 | ||
035 | |a (DE-599)GBVOLC1968369341 | ||
035 | |a (PRQ)c1942-5600b2164f5e37192fa541bd2325346c94b75347e2c41cb808bf5481f9cda7700 | ||
035 | |a (KEY)0171808820150000372000300203addressingthechallengeofgrayzonemedicine | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
084 | |a XA 10000 |q AVZ |2 rvk | ||
084 | |a 44.60 |2 bkl | ||
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Chandra, Amitabh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Addressing the challenge of gray-zone medicine |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Health care is not a binary world in which interventions are either effective or ineffective, appropriate or inappropriate. Since much health care occurs in gray zones, we need payment and incentive systems that are designed to work within those zones. | ||
650 | 4 | |a Myocardial Infarction - therapy | |
650 | 4 | |a Percutaneous Coronary Intervention - economics | |
650 | 4 | |a Percutaneous Coronary Intervention - utilization | |
650 | 4 | |a Medical care | |
650 | 4 | |a Management | |
650 | 4 | |a Angioplasty | |
650 | 4 | |a Analysis | |
650 | 4 | |a Practice guidelines (Medicine) | |
650 | 4 | |a Research | |
650 | 4 | |a Usage | |
650 | 4 | |a Health care policy | |
650 | 4 | |a Intervention | |
650 | 4 | |a Payment systems | |
650 | 4 | |a Medical research | |
700 | 1 | |a Khullar, Dhruv |4 oth | |
700 | 1 | |a Lee, Thomas H |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 372(2015), 3, Seite 203-205 |w (DE-627)129495220 |w (DE-600)207154-X |w (DE-576)014893169 |x 0028-4793 |7 nnns |
773 | 1 | 8 | |g volume:372 |g year:2015 |g number:3 |g pages:203-205 |
856 | 4 | 1 | |u http://dx.doi.org/10.1056/NEJMp1409696 |3 Volltext |
856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25587945 |
856 | 4 | 2 | |u http://search.proquest.com/docview/1645924158 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_183 | ||
912 | |a GBV_ILN_287 | ||
912 | |a GBV_ILN_290 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2012 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2219 | ||
912 | |a GBV_ILN_2414 | ||
912 | |a GBV_ILN_2424 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4256 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4310 | ||
912 | |a GBV_ILN_4315 | ||
912 | |a GBV_ILN_4320 | ||
912 | |a GBV_ILN_4323 | ||
936 | r | v | |a XA 10000 |
936 | b | k | |a 44.60 |q AVZ |
936 | b | k | |a 44.00 |q AVZ |
951 | |a AR | ||
952 | |d 372 |j 2015 |e 3 |h 203-205 |